Innoviva (INVA) Enterprise Value (2010 - 2026)
Innoviva (INVA) posted Enterprise Value of -$603.1 million for Q1 2026, down 9.46% on a QoQ basis from -$550.9 million in Q4 2025, and down 89.0% year-over-year from -$5.5 billion in Q1 2025.
Innoviva (INVA) Enterprise Value (2010 - 2026) Analysis & Trends
Innoviva's Enterprise Value history runs 17 years deep, the most recent figure standing at -$603.1 million for Q1 2026.
- Quarterly Enterprise Value fell 89.0% year-over-year to -$603.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$603.1 million (down 89.0% YoY) and the FY2025 annual result came in at -$550.9 million, down 80.66% from the prior year.
- Enterprise Value was -$603.1 million for Q1 2026 at Innoviva, down from -$550.9 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$144.0 million in Q1 2023 and bottomed at -$603.1 million in Q1 2026.
- A 5-year average of -$299.5 million and a median of -$283.6 million in 2022 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2022 — Enterprise Value sank 1469.95% — and 2023, when it jumped 40.21%.
- Innoviva's Enterprise Value stood at -$291.0 million in 2022, then jumped by 33.51% to -$193.5 million in 2023, then slumped by 57.59% to -$305.0 million in 2024, then tumbled by 80.66% to -$550.9 million in 2025, then slipped by 9.46% to -$603.1 million in 2026.
- Business Quant data shows INVA's Enterprise Value at -$603.1 million in Q1 2026, -$550.9 million in Q4 2025, and -$476.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Innoviva | 1.57 Bn | 969.11 Mn | 75.83 Mn | -603.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -603.09 Mn |
| Dec 31, 2025 | -550.94 Mn |
| Sep 30, 2025 | -476.51 Mn |
| Jun 30, 2025 | -397.53 Mn |
| Mar 31, 2025 | -319.09 Mn |
| Dec 31, 2024 | -304.96 Mn |
| Sep 30, 2024 | -260.63 Mn |
| Jun 30, 2024 | -217.00 Mn |
| Mar 31, 2024 | -178.36 Mn |
| Dec 31, 2023 | -193.51 Mn |
| Sep 30, 2023 | -180.00 Mn |
| Jun 30, 2023 | -173.03 Mn |
| Mar 31, 2023 | -144.05 Mn |
| Dec 31, 2022 | -291.05 Mn |
| Sep 30, 2022 | -301.07 Mn |
| Jun 30, 2022 | -283.58 Mn |
| Mar 31, 2022 | -216.80 Mn |
| Dec 31, 2021 | -90.33 Mn |
| Sep 30, 2021 | -46.12 Mn |
| Jun 30, 2021 | 20.70 Mn |